ISG15 is a ubiquitin-like type I IFN-stimulated protein of 15 kDa and is one of the most prominently expressed proteins in viral infections. ISG15 is widely known to be involved in a process called ISGylation, where it binds to over 150 targets from a variety of classes of proteins including central immune signaling pathways such as those mediated by NFκB, JNK, and IRF-3. However, ISG15 also exists in a free form that can act intra- or extracellularly. In vitro and in vivo evidences suggest that free ISG15 play different roles in several cellular processes, from cancer and defense against viral infections to activation of immune cells such as lymphocytes, monocytes, and NK cells. This review discusses the roles of free intracellular and secreted ISG15 approaching questions yet to be answered about the mechanism of action of this protein.
Get full access to this article
View all access options for this article.
References
1.
AndersenJB, HasselBA. 2006. The interferon regulated ubiquitin-like protein, ISG15, in tumorigenesis: friend or foe?. Cytokine Growth Factor Rev, 17(6):411–421.
2.
AuronPE, WebbAC, RosenwasserLJ, MucciSF, RichA, WolffSM, DinarelloCA. 1984. Nucleotide sequence of human monocyte interleukin 1 precursor cDNA. Proc Natl Acad Sci U S A, 81(24):7907–7911.
3.
BaechlerEC, BatliwallaFM, KarypisG, GaffneyPM, OrtmannWA, EspeKJ, SharkKB, GrandeWJ, HughesKM, KapurV, GregersenPK, BehrensTW. 2003. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci U S A, 100(5):2610–2615.
4.
BektasN, NoetzelE, VeeckJ, PressMF, KristiansenG, NaamiA, HartmannA, DimmlerA, BeckmannMW, KnuchelR, FaschingPA, DahlE. 2008. The ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) is a potential prognostic marker in human breast cancer. Breast Cancer Res, 10(4):R58.
BurksJ, ReedRE, DesaiSD. 2015. Free ISG15 triggers an antitumor immune response against breast cancer: a new perspective. Oncotarget, 6(9):7221–7231.
10.
CareMA, StephensonSJ, BarnesNA, FanI, ZougmanA, El-SherbinyYM, VitalEM, WestheadDR, ToozeRM, DoodyGM. 2016. Network Analysis Identifies Proinflammatory Plasma Cell Polarization for Secretion of ISG15 in Human Autoimmunity. J Immunol, 197(4):1447–1459.
11.
D'CunhaJ, KnightEJr., HaasAL, TruittRL, BordenEC.1996a. Immunoregulatory properties of ISG15, an interferon-induced cytokine. Proc Natl Acad Sci U S A, 93(1):211–215.
12.
D'CunhaJ, RamanujamS, WagnerRJ, WittPL, KnightEJr., BordenEC. 1996b. In vitro and in vivo secretion of human ISG15, an IFN-induced immunomodulatory cytokine. J Immunol, 157(9):4100–4108.
13.
DasturA, BeaudenonS, KelleyM, KrugRM, HuibregtseJM. 2006. Herc5, an interferon-induced HECT E3 enzyme, is required for conjugation of ISG15 in human cells. J Biol Chem, 281(7):4334–4338.
14.
de VeerMJ, HolkoM, FrevelM, WalkerE, DerS, ParanjapeJM, SilvermanRH, WilliamsBR. 2001. Functional classification of interferon-stimulated genes identified using microarrays. J Leukoc Biol, 69(6):912–920.
15.
DerSD, ZhouA, WilliamsBR, SilvermanRH. 1998. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc Natl Acad Sci U S A, 95(26):15623–15628.
16.
DesaiSD, HaasAL, WoodLM, TsaiYC, PestkaS, RubinEH, SaleemA, NurEKA, LiuLF. 2006. Elevated expression of ISG15 in tumor cells interferes with the ubiquitin/26S proteasome pathway. Cancer Res, 66(2):921–928.
17.
DesaiSD, ReedRE, BurksJ, WoodLM, PullikuthAK, HaasAL, LiuLF, BreslinJW, MeinersS, SankarS. 2012. ISG15 disrupts cytoskeletal architecture and promotes motility in human breast cancer cells. Exp Biol Med (Maywood), 237(1):38–49.
18.
DesaiSD, WoodLM, TsaiYC, HsiehTS, MarksJR, ScottGL, GiovanellaBC, LiuLF. 2008. ISG15 as a novel tumor biomarker for drug sensitivity. Mol Cancer Ther, 7(6):1430–1439.
19.
EskildsenS, JustesenJ, SchierupMH, HartmannR. 2003. Characterization of the 2'-5'-oligoadenylate synthetase ubiquitin-like family. Nucleic Acids Res, 31(12):3166–3173.
20.
FarrellPJ, BroezeRJ, LengyelP. 1979. Accumulation of an mRNA and protein in interferon-treated Ehrlich ascites tumour cells. Nature, 279(5713):523–525.
21.
FengX, WuH, GrossmanJM, HanvivadhanakulP, FitzGeraldJD, ParkGS, DongX, ChenW, KimMH, WengHH, FurstDE, GornA, McMahonM, TaylorM, BrahnE, HahnBH, TsaoBP. 2006. Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus. Arthritis Rheum, 54(9):2951–2962.
22.
FlynnJL, ChanJ, TrieboldKJ, DaltonDK, StewartTA, BloomBR. 1993. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med, 178(6):2249–2254.
23.
Francois-NewtonV, LivingstoneM, Payelle-BrogardB, UzeG, PellegriniS. 2012. USP18 establishes the transcriptional and anti-proliferative interferon alpha/beta differential. Biochem J, 446(3):509–516.
24.
FranklinBS, BossallerL, De NardoD, RatterJM, StutzA, EngelsG, BrenkerC, NordhoffM, MirandolaSR, Al-AmoudiA, ManganMS, ZimmerS, MonksBG, FrickeM, SchmidtRE, EspevikT, JonesB, JarnickiAG, HansbroPM, BustoP, Marshak-RothsteinA, HornemannS, AguzziA, KastenmullerW, LatzE. 2014. The adaptor ASC has extracellular and 'prionoid' activities that propagate inflammation. Nat Immunol, 15(8):727–737.
25.
GiannakopoulosNV, ArutyunovaE, LaiC, LenschowDJ, HaasAL, VirginHW. 2009. ISG15 Arg151 and the ISG15-conjugating enzyme UbE1 L are important for innate immune control of Sindbis virus. J Virol, 83(4):1602–1610.
26.
GiannakopoulosNV, LuoJK, PapovV, ZouW, LenschowDJ, JacobsBS, BordenEC, LiJ, VirginHW, ZhangDE. 2005. Proteomic identification of proteins conjugated to ISG15 in mouse and human cells. Biochem Biophys Res Commun, 336(2):496–506.
27.
GuerraS, CaceresA, KnobelochKP, HorakI, EstebanM. 2008. Vaccinia virus E3 protein prevents the antiviral action of ISG15. PLoS Pathog, 4(7):e1000096.
28.
HaasAL, AhrensP, BrightPM, AnkelH. 1987. Interferon induces a 15-kilodalton protein exhibiting marked homology to ubiquitin. J Biol Chem, 262(23):11315–11323.
29.
HareNJ, ChanB, ChanE, KaufmanKL, BrittonWJ, SaundersBM. 2015. Microparticles released from Mycobacterium tuberculosis-infected human macrophages contain increased levels of the type I interferon inducible proteins including ISG15. Proteomics, 15(17):3020–3029.
30.
HoanNX, Van TongH, GiangDP, ToanNL, MeyerCG, BockCT, KremsnerPG, SongLH, VelavanTP. 2016. Interferon-stimulated gene 15 in hepatitis B-related liver diseases. Oncotarget.
31.
HogquistKA, UnanueER, ChaplinDD. 1991. Release of IL-1 from mononuclear phagocytes. J Immunol, 147(7):2181–2186.
JeonYJ, ChoiJS, LeeJY, YuKR, KaSH, ChoY, ChoiEJ, BaekSH, SeolJH, ParkD, BangOS, ChungCH. 2008. Filamin B serves as a molecular scaffold for type I interferon-induced c-Jun NH2-terminal kinase signaling pathway. Mol Biol Cell, 19(12):5116–5130.
34.
JeonYJ, ChoiJS, LeeJY, YuKR, KimSM, KaSH, OhKH, KimKI, ZhangDE, BangOS, ChungCH. 2009. ISG15 modification of filamin B negatively regulates the type I interferon-induced JNK signalling pathway. EMBO Rep, 10(4):374–380.
35.
KiesslingA, HogrefeC, ErbS, BobachC, FuesselS, WessjohannL, SeligerB. 2009. Expression, regulation and function of the ISGylation system in prostate cancer. Oncogene, 28(28):2606–2620.
36.
KimMJ, HwangSY, ImaizumiT, YooJY. 2008. Negative feedback regulation of RIG-I-mediated antiviral signaling by interferon-induced ISG15 conjugation. J Virol, 82(3):1474–1483.
37.
KirouKA, LeeC, GeorgeS, LoucaK, PetersonMG, CrowMK. 2005. Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease. Arthritis Rheum, 52(5):1491–1503.
38.
KnightEJr., CordovaB. 1991. IFN-induced 15-kDa protein is released from human lymphocytes and monocytes. J Immunol, 146(7):2280–2284.
39.
KnightEJr., FaheyD, CordovaB, HillmanM, KutnyR, ReichN, BlomstromD.1988. A 15-kDa interferon-induced protein is derived by COOH-terminal processing of a 17-kDa precursor. J Biol Chem, 263(10):4520–4522.
40.
KorantBD, BlomstromDC, JonakGJ, KnightEJr. 1984. Interferon-induced proteins. Purification and characterization of a 15,000-dalton protein from human and bovine cells induced by interferon. J Biol Chem, 259(23):14835–14839.
MalakhovaOA, KimKI, LuoJK, ZouW, KumarKG, FuchsSY, ShuaiK, ZhangDE. 2006. UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activity. EMBO J, 25(11):2358–2367.
53.
MalakhovaOA, ZhangDE. 2008. ISG15 inhibits Nedd4 ubiquitin E3 activity and enhances the innate antiviral response. J Biol Chem, 283(14):8783–8787.
54.
MantovaniA, SozzaniS, LocatiM, AllavenaP, SicaA. 2002. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol, 23(11):549–555.
55.
MerrittEA, ArakakiTL, LarsonET, KelleyA, MuellerN, NapuliAJ, ZhangL, DedittaG, LuftJ, VerlindeCL, FanE, ZuckerF, BucknerFS, Van VoorhisWC, HolWG. 2010. Crystal structure of the aspartyl-tRNA synthetase from Entamoeba histolytica. Mol Biochem Parasitol, 169(2):95–100.
56.
MinakawaM, SoneT, TakeuchiT, YokosawaH. 2008. Regulation of the nuclear factor (NF)-kappaB pathway by ISGylation. Biol Pharm Bull, 31(12):2223–2227.
57.
MoralesDJ, LenschowDJ. 2013. The antiviral activities of ISG15. J Mol Biol, 425(24):4995–5008.
58.
NaegelenI, BeaumeN, PlanconS, SchentenV, TschirhartEJ, BrechardS. 2015. Regulation of Neutrophil Degranulation and Cytokine Secretion: A Novel Model Approach Based on Linear Fitting. J Immunol Res, 2015:817038.
59.
OkumuraA, LuG, Pitha-RoweI, PithaPM. 2006. Innate antiviral response targets HIV-1 release by the induction of ubiquitin-like protein ISG15. Proc Natl Acad Sci U S A, 103(5):1440–1445.
60.
OkumuraA, PithaPM, HartyRN. 2008. ISG15 inhibits Ebola VP40 VLP budding in an L-domain-dependent manner by blocking Nedd4 ligase activity. Proc Natl Acad Sci U S A, 105(10):3974–3979.
61.
OkumuraF, OkumuraAJ, UematsuK, HatakeyamaS, ZhangDE, KamuraT. 2013. Activation of double-stranded RNA-activated protein kinase (PKR) by interferon-stimulated gene 15 (ISG15) modification down-regulates protein translation. J Biol Chem, 288(4):2839–2847.
62.
OwhashiM, TaokaY, IshiiK, NakazawaS, UemuraH, KambaraH. 2003. Identification of a ubiquitin family protein as a novel neutrophil chemotactic factor. Biochem Biophys Res Commun, 309(3):533–539.
63.
PadovanE, TerraccianoL, CertaU, JacobsB, ReschnerA, BolliM, SpagnoliGC, BordenEC, HebererM. 2002. Interferon stimulated gene 15 constitutively produced by melanoma cells induces e-cadherin expression on human dendritic cells. Cancer Res, 62(12):3453–3458.
64.
ParkJH, YangSW, ParkJM, KaSH, KimJH, KongYY, JeonYJ, SeolJH, ChungCH. 2016. Positive feedback regulation of p53 transactivity by DNA damage-induced ISG15 modification. Nat Commun, 7:12513.
65.
PizziraniC, FerrariD, ChiozziP, AdinolfiE, SandonaD, SavaglioE, Di VirgilioF. 2007. Stimulation of P2 receptors causes release of IL-1beta-loaded microvesicles from human dendritic cells. Blood, 109(9):3856–3864.
66.
QuY, FranchiL, NunezG, DubyakGR. 2007. Nonclassical IL-1 beta secretion stimulated by P2X7 receptors is dependent on inflammasome activation and correlated with exosome release in murine macrophages. J Immunol, 179(3):1913–1925.
67.
RajkumarT, SabithaK, VijayalakshmiN, ShirleyS, BoseMV, GopalG, SelvaluxmyG. 2011. Identification and validation of genes involved in cervical tumourigenesis. BMC Cancer, 11:80.
68.
RechtM, BordenEC, KnightEJr. 1991. A human 15-kDa IFN-induced protein induces the secretion of IFN-gamma. J Immunol, 147(8):2617–2623.
69.
RubartelliA, CozzolinoF, TalioM, SitiaR. 1990. A novel secretory pathway for interleukin-1 beta, a protein lacking a signal sequence. EMBO J, 9(5):1503–1510.
70.
SadlerAJ, WilliamsBR. 2007. Structure and function of the protein kinase R. Curr Top Microbiol Immunol, 316:253–292.
71.
SainzBJr., MartinB, TatariM, HeeschenC, GuerraS.2014. ISG15 is a critical microenvironmental factor for pancreatic cancer stem cells. Cancer Res, 74(24):7309–7320.
72.
SchreiberG, PiehlerJ. 2015. The molecular basis for functional plasticity in type I interferon signaling. Trends Immunol, 36(3):139–149.
73.
SheedyFJ, GrebeA, RaynerKJ, KalantariP, RamkhelawonB, CarpenterSB, BeckerCE, EdiriweeraHN, MullickAE, GolenbockDT, StuartLM, LatzE, FitzgeraldKA, MooreKJ. 2013. CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation. Nat Immunol, 14(8):812–820.
74.
ShiHX, YangK, LiuX, LiuXY, WeiB, ShanYF, ZhuLH, WangC. 2010. Positive regulation of interferon regulatory factor 3 activation by Herc5 via ISG15 modification. Mol Cell Biol, 30(10):2424–2436.
SrinivasulaSM, PoyetJL, RazmaraM, DattaP, ZhangZ, AlnemriES. 2002. The PYRIN-CARD protein ASC is an activating adaptor for caspase-1. J Biol Chem, 277(24):21119–21122.
77.
SunL, WangX, ZhouY, ZhouRH, HoWZ, LiJL. 2016. Exosomes contribute to the transmission of anti-HIV activity from TLR3-activated brain microvascular endothelial cells to macrophages. Antiviral Res, 134:167–171.
78.
TakeuchiT, YokosawaH. 2005. ISG15 modification of Ubc13 suppresses its ubiquitin-conjugating activity. Biochem Biophys Res Commun, 336(1):9–13.
79.
TangY, ZhongG, ZhuL, LiuX, ShanY, FengH, BuZ, ChenH, WangC. 2010. Herc5 attenuates influenza A virus by catalyzing ISGylation of viral NS1 protein. J Immunol, 184(10):5777–5790.
80.
ThavachelvamK, GadHH, IbsenMS, DespresP, HoklandM, HartmannR, KristiansenH. 2015. Rapid Uptake and Inhibition of Viral Propagation by Extracellular OAS1. J Interferon Cytokine Res, 35(5):359–366.
81.
WongJJ, PungYF, SzeNS, ChinKC. 2006. HERC5 is an IFN-induced HECT-type E3 protein ligase that mediates type I IFN-induced ISGylation of protein targets. Proc Natl Acad Sci U S A, 103(28):10735–10740.
82.
WoodLM, PanZK, SeaveyMM, MuthukumaranG, PatersonY. 2012. The ubiquitin-like protein, ISG15, is a novel tumor-associated antigen for cancer immunotherapy. Cancer Immunol Immunother, 61(5):689–700.
83.
YangPM, WangJT, ChiangBL, LaiMY, ChenDS. 1997. Serum 2',5'-oligoadenylate synthetase concentrations in acute and chronic hepatitis C. J Formos Med Assoc, 96(5):314–319.
84.
YaoY, RichmanL, HiggsBW, MorehouseCA, de los ReyesM, BrohawnP, ZhangJ, WhiteB, CoyleAJ, KienerPA, JallalB. 2009. Neutralization of interferon-alpha/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus. Arthritis Rheum, 60(6):1785–1796.
85.
YuanW, KrugRM. 2001. Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein. EMBO J, 20(3):362–371.
86.
ZengZ, XuX, ZhangY, XingJ, LongJ, GuL, WangX, SunD, KaW, YaoW, WenZ, ChienS. 2007. Tumor-derived factors impaired motility and immune functions of dendritic cells through derangement of biophysical characteristics and reorganization of cytoskeleton. Cell Motil Cytoskeleton, 64(3):186–198.
ZhaoC, BeaudenonSL, KelleyML, WaddellMB, YuanW, SchulmanBA, HuibregtseJM, KrugRM. 2004. The UbcH8 ubiquitin E2 enzyme is also the E2 enzyme for ISG15, an IFN-alpha/beta-induced ubiquitin-like protein. Proc Natl Acad Sci U S A, 101(20):7578–7582.
89.
ZhaoC, DenisonC, HuibregtseJM, GygiS, KrugRM. 2005. Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways. Proc Natl Acad Sci U S A, 102(29):10200–10205.
90.
ZhaoC, HsiangTY, KuoRL, KrugRM. 2010. ISG15 conjugation system targets the viral NS1 protein in influenza A virus-infected cells. Proc Natl Acad Sci U S A, 107(5):2253–2258.
91.
ZouW, KimJH, HandiduA, LiX, KimKI, YanM, LiJ, ZhangDE. 2007. Microarray analysis reveals that Type I interferon strongly increases the expression of immune-response related genes in Ubp43 (Usp18) deficient macrophages. Biochem Biophys Res Commun, 356(1):193–199.
